Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
- PMID: 40857027
- PMCID: PMC12670333
- DOI: 10.1002/ijc.70090
Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
Abstract
Human fatty acid binding protein-4 (FABP-4), a protein elevated in obesity that promotes colon cancer cell invasiveness and metastasis, may be associated with higher mortality in individuals with colorectal cancer (CRC) and may serve as a mediator of the obesity-mortality association in these individuals. We used a causal diagram to inform covariate selection and applied Cox proportional hazards models to estimate hazard ratios (HRs) for CRC-specific, non-CRC-specific, and all-cause mortality by FABP-4 levels measured in baseline blood samples from 1371 incident CRC cases from the European Prospective Investigation into Cancer and Nutrition cohort. Competing risk analyses were adapted for CRC and non-CRC deaths. Mediation analyses were conducted to estimate total effects (TEs), direct effects (DEs), and mediation proportions (MPs) by FABP-4 of pre-diagnostic body mass index (BMI) on mortality. In the fully adjusted model including BMI, higher circulating FABP-4 concentrations were associated with higher CRC mortality (HRQ4vsQ1 = 1.49; 95% CI: 1.11-2.00) and all-cause mortality (HRQ4vsQ1 = 1.49; 95% CI: 1.15-1.93), but not statistically associated with non-CRC mortality (HRQ4vsQ1 = 1.51; 95% CI: 0.82-2.76). The TE and DE per 5 kg/m2 of BMI on all-cause mortality were 1.21; 95% CI: 1.10-1.34, and 1.13; 95% CI: 1.02-1.26, respectively, with a MP of 34.5% (p = .002) by FABP-4. For CRC-specific and non-CRC-specific mortality, MPs by FABP-4 were 33.7% (p = .03) and 36.1% (p = .02), respectively. In conclusion, higher concentrations of FABP-4 were associated with higher CRC-specific and all-cause mortality in individuals with CRC. FABP-4 was a significant partial mediator of the adiposity-mortality relationship in individuals with CRC.
Keywords: EPIC; FABP‐4; human fatty acid binding protein‐4; incident colorectal cancer; mortality.
© 2025 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1‐253. - PubMed
-
- Fedirko V, Romieu I, Aleksandrova K, et al. Pre‐diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations. Int J Cancer. 2014;135:1949‐1960. - PubMed
MeSH terms
Substances
Grants and funding
- Health Research Fund (FIS)-Instituto de Salud Carlos III (ISCIII)
- Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy
- Netherlands Cancer Registry (NKR)
- Compagnia di SanPaolo and National Research Council
- Dutch Ministry of Public Health, Welfare and Sports (VWS)
- German Cancer Aid
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
- German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Statistics Netherlands (The Netherlands)
- Dutch ZON (Zorg Onderzoek Nederland)
- Dutch Prevention Funds
- Swedish Research Council and County Councils of Skåne and Västerbotten
- Federal Ministry of Education and Research (BMBF)
- LK Research Funds
- Danish Cancer Society
- Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology-ICO
- World Cancer Research Fund (WCRF)
- International Agency for Research on Cancer (IARC)
- Institut Gustave Roussy
- Mutuelle Générale de l'Education Nationale
- 001/WHO_/World Health Organization/International
- Swedish Cancer Society
- Ligue Contre le Cancer
- German Cancer Research Center (DKFZ)
- 14136 to EPIC-Norfolk; C8221/A29017 to EPIC-Oxford/CRUK_/Cancer Research UK/United Kingdom
- 1000143 to EPIC-Norfolk; MR/M012190/1 to EPIC-Oxford/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Research Materials
